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Interventional Cardiology
DES Reduce Revascularization by 43% in Real-World Registry
Abbott and colleagues investigated the effectiveness and safety of drug-elutingstents (DES) as used in routine clinical practice inNorth America. Patients in the
Dynamic Registry, sponsored by the National Heart, Lung, and Blood Institute, who
received at least one DES were compared with patients who received at least one
bare-metal stent (BMS) prior to the introduction of DES. At 1 year, there was no
difference in the cumulative rate of death or myocardial infarction. The rate of
target vessel revascularization was 5.0% in DES and 9.2% in BMS patients,
and similar reductions were observed in complex and simple lesion types. These
findings support the use of DES compared with BMS in real-world experience.
See page 2029. See figure.
Coronary Artery Disease
Pioglitazone Improves MBF in Patients With FCHL
Familial combined hyperlipidemia (FCHL) is a complex genetic disorder charac-terized by high serum cholesterol, low high-density lipoprotein (HDL) choles-
terol, insulin resistance, and premature coronary atherosclerosis. Naoumova and col-
leagues studied the effect of pioglitazone on serum lipid parameters and myocardial
blood flow (MBF) andmyocardial glucose utilization (MGU) using positron emission
tomographic scanning in patients with FCHL. Subjects randomized to pioglitazone
showed significant increases in MGU and resting MBF. These effects were accompa-
nied by a 28% increase inHDL and a 35% decrease in serum insulin. In patients with
FCHL, the addition of pioglitazone led to significant improvements in MGU
and MBF, with a favorable effect on serum lipid and metabolic parameters.
See page 2051.
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Biomarkers
H-FABP Improves Risk Stratification in ACS Patients
Heart-type fatty acid-binding protein (H-FABP) is released into the circulationfollowing myocardial ischemia, possibly within as little as 15 min. The
EMMACE-2 trial enrolled patients with suspected acute coronary syndrome (ACS),
and H-FABP levels were measured 12 to 24 h after symptom onset. The all-cause
1-yearmortality for subjects withH-FABP5.8g/l was 2% versus 23% for patients
above this level. This assay provided complementary information to measurement of
troponin; no patients with low H-FABP and negative troponin levels died during the
next 6 months. Heart-type fatty acid-binding protein predicts 1-year mortality after
ACS and identifies high-risk patients in amanner that is additive to clinical risk factors
and troponin. Heart-type fatty acid-binding protein may be able to detect myocardial
ischemia with or without necrosis. See page 2061. See figure.
(continued) A-32Surgery for Congenital Disease
Stress Testing Following Surgical Repair of Anomalous Coronary Arteries
Anomalous aortic origin of a coronary artery that courses between the 2 great vessels(AAOCA) is a rare anomaly that carries an increased risk for sudden cardiac death.
Brothers and colleagues measured the effectiveness of surgical repair to normalize
cardiac perfusion by performing various modalities of stress testing. Twenty-four
children who underwent AAOCA surgery underwent an exercise stress test, stress
echocardiogram, and stressmyocardial perfusion scans 1 year after surgical repair. One
of 8 patients with repair of an anomalous left coronary artery had a stress test suggestive
of inducible ischemia versus 50% of the anomalous right coronary artery patients.
Abnormal stress testing occurs frequently after AAOCA repair, especially after anom-
alous right coronary artery repair. Further studies are needed to determine if an
abnormal stress test confers a worse prognosis in this population. See page 2078.
Hypertension
Cigarette Smoking Modestly Increases Risk of Developing Hypertension
The relationship between cigarette smoking and hypertension is poorly under-stood.Bowman and colleagues assessed the use of cigarettes in the 28,000women
who participated in the Women’s Health Study who did not have hypertension at
baseline and who were then followed for 10 years. There was a trend between cigarette
use and the development of hypertension that became statistically significant for those
who smoked 15 cigarettes per day. The hazard ratio among women who smoked
25 cigarettes per day was 1.2. This study suggests that cigarette use does confer an
increased risk for developing hypertension, although confounding risk factors cannot
be excluded by this study design. See page 2085.
